These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9724626)

  • 21. Molecular properties of complexes formed between the prion protein and synthetic peptides.
    Kaneko K; Wille H; Mehlhorn I; Zhang H; Ball H; Cohen FE; Baldwin MA; Prusiner SB
    J Mol Biol; 1997 Jul; 270(4):574-86. PubMed ID: 9245588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
    Dima RI; Thirumalai D
    Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
    Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ
    Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The crystal structure of zinc-containing ferredoxin from the thermoacidophilic archaeon Sulfolobus sp. strain 7.
    Fujii T; Hata Y; Oozeki M; Moriyama H; Wakagi T; Tanaka N; Oshima T
    Biochemistry; 1997 Feb; 36(6):1505-13. PubMed ID: 9063899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S; Glockshuber R
    J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
    Havsteen BH
    J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion protein peptides induce alpha-helix to beta-sheet conformational transitions.
    Nguyen J; Baldwin MA; Cohen FE; Prusiner SB
    Biochemistry; 1995 Apr; 34(13):4186-92. PubMed ID: 7703230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The determinants of stability in the human prion protein: insights into folding and misfolding from the analysis of the change in the stabilization energy distribution in different conditions.
    Colacino S; Tiana G; Broglia RA; Colombo G
    Proteins; 2006 Mar; 62(3):698-707. PubMed ID: 16432880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the 132-160 region in prion protein conformational transitions.
    Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
    Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
    Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
    Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion protein alpha-to-beta transition monitored by time-resolved Fourier transform infrared spectroscopy.
    Ollesch J; Künnemann E; Glockshuber R; Gerwert K
    Appl Spectrosc; 2007 Oct; 61(10):1025-31. PubMed ID: 17958950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.
    Lee S; Eisenberg D
    Nat Struct Biol; 2003 Sep; 10(9):725-30. PubMed ID: 12897768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of hydrophobic interactions in amyloidogenesis: example of prion-related polypeptides.
    Tcherkasskaya O; Sanders W; Chynwat V; Davidson EA; Orser CS
    J Biomol Struct Dyn; 2003 Dec; 21(3):353-65. PubMed ID: 14616031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PrP27-30 is a normal soluble prion protein fragment released by human platelets.
    Perini F; Vidal R; Ghetti B; Tagliavini F; Frangione B; Prelli F
    Biochem Biophys Res Commun; 1996 Jun; 223(3):572-7. PubMed ID: 8687437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
    Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
    J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanism for low pH triggered misfolding of the human prion protein.
    DeMarco ML; Daggett V
    Biochemistry; 2007 Mar; 46(11):3045-54. PubMed ID: 17315950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR.
    Wong E; Thackray AM; Bujdoso R
    Biochem J; 2004 May; 380(Pt 1):273-82. PubMed ID: 14969585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
    Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
    Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.